Within this context, Greece is actively strengthening its role within the European HTA ecosystem, adapting its structures, processes and capabilities to align with emerging EU practices while addressing national healthcare priorities.

At the same time, rapid advancements in innovative therapies, digital health, artificial intelligence and real-world data are transforming the evidence base and challenging traditional HTA approaches.

By bringing together leading experts from Greece and across Europe, the 11th HTA Conference aims to contribute to a shared vision of HTA that is collaborative, evidence-based, and capable of supporting innovation while ensuring equitable patient access across healthcare systems.

Through focused discussions and high-level dialogue, the event will highlight how Greece and Europe can work together to accelerate access to innovation, strengthen evidence-based decision-making and ensure equitable outcomes for patients across health systems.

• The EU HTA Regulation: Strengthening European Collaboration
  With the implementation of the EU HTA Regulation, Member States are entering a new era of structured cooperation through Joint Clinical Assessments (JCAs), common methodologies, and shared evidence generation. The conference will explore how European collaboration is reshaping HTA processes and what this means for national decision-making.
• Greece within the European HTA Ecosystem
  As Greece continues to develop and strengthen its HTA framework, the conference will examine how national systems can effectively align with European processes while addressing local healthcare priorities.
• Cross-Country Collaboration in Evidence Generation
  A key pillar of the new HTA landscape is the growing collaboration among European countries in generating and assessing evidence. Discussions will focus on how shared data, coordinated research efforts, and international initiatives can support more robust and efficient evaluations.

• Innovation and Access Across European Health Systems
  As breakthrough therapies and advanced technologies continue to emerge, European healthcare systems face the challenge of ensuring timely and equitable access to innovation while maintaining sustainability.
• Data, Artificial Intelligence and the Future of HTA
  Digital transformation and AI are increasingly shaping how evidence is generated, analyzed, and applied in healthcare decision-making. Sessions will explore how data-driven approaches can strengthen HTA methodologies and support more informed policy decisions.
• Patient Engagement in a European HTA Framework
  Patient involvement is becoming a central component of modern HTA processes. The conference will highlight how meaningful patient engagement can be integrated into both national and European HTA frameworks.

• Policymakers and government representatives
• HTA authorities and regulators
• Pharmaceutical and medical technology industry executives
• Health economists and market access professionals
• Healthcare providers
• Academics and researchers
• Patient organizations and advocacy groups

• Gain insights into the evolving European HTA landscape
• Explore the role of Greece within the European HTA ecosystem
• Exchange perspectives with leading European and national stakeholders
• Discover new approaches to evidence generation and data-driven decision making
• Contribute to shaping collaborative and sustainable healthcare systems